| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.13 | 0.5 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.5 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |